Nexo Therapeutics
Anna Ericsson has an extensive background in chemistry, with experience ranging from research investigator roles at pharmaceutical companies like Bristol-Myers Squibb to positions as a principal scientist at FORMA Therapeutics. With a PhD in Organic Chemistry from Uppsala University and a Bachelor's degree in Chemistry from MidSweden University, Anna currently serves as the Director of Chemistry at nexo therapeutics.
Nexo Therapeutics
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.